Equities researchers at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued on Friday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their price objective on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
Read Our Latest Stock Analysis on Veradigm
Veradigm Stock Down 1.2 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Canadian Penny Stocks: Can They Make You Rich?
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
